News | October 16, 2024
Lupin launches first generic of Pred Forte in US
Prednisolone Acetate Ophthalmic Suspension is the first generic version of Pred Forte
Prednisolone Acetate Ophthalmic Suspension is the first generic version of Pred Forte
GBM affects nearly 13,000 patients annually in the US and approximately 300,000 globally
Indoco is comprehensively working on the remedial action plan
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
HYMPAVZI’s approval is based on Phase 3 study results demonstrating substantial bleed reduction compared to routine prophylaxis
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
Paliperidone extended-release tablets will be produced at the Group’s manufacturing site at SEZ, Ahmedabad
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Based on ECHO Phase III trial which demonstrated Calquence combination reduced risk of disease progression or death by 27% compared to standard-of-care chemoimmunotherapy
Subscribe To Our Newsletter & Stay Updated
